Latest filing published 18 Dec 2017 for MPX Bioceutical Corporation.
No signal scores available.
Naser Bin Butti Almheiri is a declared insider of MPX Bioceutical Corporation, with filings sourced from SEDI. We count 16 filings; the first trade dates from 13 November 2017 and the latest from 15 December 2017.
No open-market purchase appears, only 16 sales. The totals exclude 16 filings filed without an amount.
The latest filing, published on 18 December 2017, reports an open-market sale in MPX Bioceutical Corporation. Typically, a trade is published a median of 2 days after it takes place. Until a filing is published, the market cannot know about the trade. Keep in mind that insiders sell for many reasons unrelated to the outlook, from tax bills to estate planning. These figures are compiled from regulatory filings published by SEDI. They describe what insiders did and are not a recommendation.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
16 of 16 declarations